Michael Perrine
Director
Business Development
Agilvax
United States of America
Biography
Michael Perrine has most recently overseen the development and transition of Azano Biotech into an organization focused on providing the scientific community with essential research use tools to promote biomedical discoveries and breakthroughs. Mr. Perrine is excited to bring his talents to Agilvax to aid in the commercialization efforts of the unique VLP technology platform. Mr. Perrine has attained an extensive technical and business understanding of the biotechnology industry through his research and development work at Azano Biotech, Exagen Diagnostics, nanoMR, and Physiogenix. Mr. Perrine was part of research teams that developed a novel breast cancer prognostic assay, a noninvasive assay for the diagnosis of gastrointestinal diseases, a rapid assay for the detection of sepsis, and performed preclinical pharmaceutical screening of early stage hypertension and diabetes therapeutics. Mr. Perrine holds an MBA from the University of New Mexico's Anderson School of Management and an MS in Physiology from the Medical College of Wisconsin.
Research Interest
Business and Management
